Afinion 2 builds on Abbott’s heritage in diabetes care by empowering patients with information about their health that they can discuss with their providers during a single visit.

The Afinion 2 analyzer is a compact rapid, multi-assay platform that streamlines and simplifies the delivery of actionable, accurate measurements of hemoglobin A1c (HbA1c) and albumin to creatinine ratio (ACR) results at the point of care. The system arms healthcare professionals with the information needed to make fast and accurate medical decisions—three minutes for HbA1c and five minutes for ACR—enabling healthcare professionals to dedicate more time to counseling patients within a single office visit.

Along with providing rapid results, the Afinion 2 platform now also offers all-in-one connectivity to LIS/HIS (laboratory and hospital information systems) and a sleeker, quieter experience for clinicians and patients. Healthcare professionals can use the Afinion 2 analyzer in a wide range of out-patient settings—including physician offices, clinics, community health centers, hospitals and long-term care facilities.

“By delivering rapid HbA1c and ACR test results, the Afinion 2 analyzer does more than streamline care; its life-changing technology helps people living with diabetes get the most out of their healthcare visits,” said Elizabeth Balthrop, divisional vice president, Cardiometabolic and Informatics, Abbott. “Within a single visit, patients can obtain real-time feedback and insights on their condition, have an informed discussion with their provider and leave with a defined care plan.”